Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FORGOTTEN HISTORY: 2 | History Defined

Snag This Biotech Stock Before November, Here's Why

With Viking Therapeutics making a splash in the weight-loss drug arena, one analyst is encouraging investors to snap up the stock before a November catalyst.

3 'Strong-Buy'-Rated Russell 2000 Stocks With 54% to 110% Upside

3 'Strong-Buy'-Rated Russell 2000 Stocks With 54% to 110% Upside

Investing in these small caps could be rewarding in the long run.

Structure Therapeutics vs. Viking Therapeutics: Which Weight-Loss Drug Stock Wins?

Structure Therapeutics vs. Viking Therapeutics: Which Weight-Loss Drug Stock Wins?

With weight-loss drugs gaining traction, which biopharma stock wins?

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

5 Breakout Biotech Stocks Leading the Russell 2000 Higher

These small-cap biotech stocks are rallying hard in 2024, and still have room to keep leading the RUT higher.

3 'Strong Buy' Growth Stocks to Scoop Up Now

High-growth stocks, such as cybersecurity name Zscaler, could be part of your equity portfolio in 2024 - if you're the type of investor who can successfully stomach massive drawdowns in share prices and valuations.

5 Russell 2000 Stocks Outperforming the 'Magnificent Seven' in 2024

The "Magnificent Seven" have lost some momentum in 2024, just as small-caps are starting to come on strong. Here's a closer look at five Russell 2000 stocks that are crushing the performance of their mega-cap peers so far this year.

Up 283% YTD, Is It Too Late to Buy Viking Therapeutics Stock?

Shares of Viking Therapeutics have been on an absolute tear in 2024, as the biotech stock gears up to enter the weight-loss drug market.

inkl

Read news from The Economist, FT, and more,
with one subscription

Stock Market Today: Stocks End Mixed After Disappointing Economic Data

Stock Market Today: Stocks End Mixed After Disappointing Economic Data

The main indexes made muted moves Tuesday as investors took data that showed a big drop in durable goods and consumer confidence.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

The Conference Board

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play